Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials Academic Article uri icon

Overview

MeSH Major

  • Liver Failure, Acute
  • Liver Transplantation
  • Pulmonary Disease, Chronic Obstructive

abstract

  • In this SOF-experienced, NS5A inhibitor-naïve population, which included participants with cirrhosis or HCV/HIV co-infection, high SVR12 rates were achieved.

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/liv.13616

PubMed ID

  • 29091342

Additional Document Info